Company Overview and News
The state government has blocked a major residential project near Rockingham, following objections by local residents and environmentalists, with joint venturer Cedar Woods Properties saying this afternoon it was disappointed and would seek to recover its costs.
Property groups Cedar Woods Properties and Peet have both reported increases in net profit after tax for the first half of the 2018 financial year.
One of the state’s largest property holders, Perron Group, has appointed former Cedar Woods Properties managing director Paul Sadleir to its board.
Virtual reality has met reality at Cedar Woods Properties’ Bushmead Estate development near Midland, thanks to a technology called Reality Engineering.
Paul Sadleir has announced plans to retire as managing director of Cedar Woods Properties, with chief operating officer Nathan Blackburne to step into the role.
Cedar Woods Properties has found a buyer for a commercial development in Melbourne suburb Williams Landing, which is currently under construction and will become the Australian headquarters for Wesfarmers-owned department store chain Target.
Anglo American plc ("Anglo American") announces the appointment of Stephen Pearce as Finance Director, following René Médori's decision to retire, as announced in April 2016. Mr Pearce will join Anglo American and its Group Management Committee on 30 January 2017, prior to joining the Board as an executive director and taking over as Finance Director with effect from 24 April 2017, thereby enabling a smooth transition and the completion of the 2016 financial reporting process.
Cedar Woods Properties has won its second big job for South Australian government agency Renewal SA, having been appointed to redevelop 40 hectares of land at Port Adelaide.
The 101-room Vibe Marysville hotel, built with the support of the Victorian government after the deadly 2009 bushfires, has been listed for sale by Architecture firm Metier3 and the Toga Group's Vidor family.
Listen to podcasts covering breaking news, items of interest and our Success & Leadership Series events. A wide range of topics covered by our well renowned reporters and WA business leaders. Subscribe on iTunes for updates as they happen. Click here for more
12h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
12h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
22h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...